Cover 2 Resources
Cover 2 Resources
Ep. 232 - Part 4; Diversion Out of Control: Joe Rannazzisi Shares What Went Wrong
Ep. 232 - Part 4; Diversion Out of Control: Joe Rannazzisi Shares What Went Wrong
Ep. 232 - Part 4; Diversion Out of Control: Joe Rannazzisi Shares What Went Wrong
Friday 15th March 2019
Joe Rannazzisi uncovers how government officials shaped opioid policies before joining pharmaceutical companies, fueling the crisis. Listen now.
29 minutes
Informative
Thought-provoking
Raw
Engaging
Life-changing
About this podcast
Overview:
Categories:
Innovative Treatments & Recovery Paths
Family Recovery from Addiction
Sobriety Toolkit
Body & Mind
Navigating Intimate Relationships
Links:
Visit site
Episodes:
284 (View all)
Do you want to link to this podcast?
Get the buttons here!The Hidden Influence: Government Officials and the Opioid Crisis
This is the deadliest drug epidemic that this country has ever seen and it doesn't appear to be decreasing at all. Make sure you take a role in what doctor is doing for your children and your young adults.
Imagine a world where the very people responsible for regulating drugs are also the ones who later work for the companies that produce them. This episode of Cover 2 Resources dives deep into this unsettling reality. Joe Rannazzisi, a former DEA official, exposes how the Ensuring Patient Access and Effective Drug Enforcement Act stripped the DEA of its most powerful tool to combat opioid diversion.
He recounts stories of government officials and Congressmen who played pivotal roles in shaping drug policies, only to later join the pharmaceutical industry. This episode also highlights a chilling clip from 'The Sentence that Helped Set Off the Opioid Crisis', shedding light on how OxyContin was approved without clinical trials, thanks to a key FDA figure who soon after joined Purdue Pharma. It’s a revealing look at conflicts of interest and the devastating impact they’ve had on the opioid crisis.
If you’re interested in understanding the murky intersections between government and Big Pharma, this episode is a must-listen.